Barry Alperin Net Worth

The estimated Net Worth of Barry J Alperin is at least $4.94 Million dollars as of 1 December 2017. Mr. Alperin owns over 5,796 units of Henry Schein stock worth over $3,229,933 and over the last 21 years he sold HSIC stock worth over $1,392,835. In addition, he makes $318,000 as Independent Director at Henry Schein.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Alperin HSIC stock SEC Form 4 insiders trading

Barry has made over 19 trades of the Henry Schein stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 5,796 units of HSIC stock worth $173,590 on 1 December 2017.

The largest trade he's ever made was exercising 20,000 units of Henry Schein stock on 16 December 2011 worth over $428,200. On average, Barry trades about 1,730 units every 52 days since 2004. As of 1 December 2017 he still owns at least 48,172 units of Henry Schein stock.

You can see the complete history of Mr. Alperin stock trades at the bottom of the page.

Barry Alperin biography

Barry J. Alperin J.D. serves as Independent Director of the Company. He served as Vice Chairman of Hasbro, Inc. from 1990 through 1995, as Co-Chief Operating Officer of Hasbro from 1989 through 1990 and as Senior Vice President or Executive Vice President of Hasbro from 1985 through 1989. He was a director of Hasbro from 1985 through 1996. Prior to joining Hasbro, Mr. Alperin practiced law in New York City for 20 years, dealing with corporate, public and private financial transactions, corporate mergers and acquisitions, compensation issues and securities law matters. The Company values Mr. Alperin’s financial expertise and his extensive experience in corporate and securities laws and corporate governance matters. Additionally, as the Company continues to grow through strategic acquisitions, the Board of Directors values Mr. Alperin’s experience leading Hasbro’s mergers and acquisitions and global expansion efforts. Mr. Alperin currently serves as a director of Fiesta Restaurant Group, Inc. (and is Chairman of its finance committee and a member of its audit committee and nominating and governance committee) and Jefferies Group LLC, a global investment banking firm and a subsidiary of Leucadia National Corporation (and a member of its audit committee, compensation committee and corporate governance and nominating committee). Mr. Alperin is also a director of privately held corporations Weeks Marine, Inc., a marine construction company, and Sterling Drive Ventures, Inc., and a general partner of Sterling Drive Ventures L.P., a holding company for the Rodan Group, an injection molder of plastic parts. He currently serves as a trustee of The Caramoor Center for Music and the Arts (and a member of its executive committee), President Emeritus and a Life Trustee of The Jewish Museum in New York City and is a past President of the New York Chapter of the American Jewish Committee where he also served as Chair of the audit committee of the national organization.

What is the salary of Barry Alperin?

As the Independent Director of Henry Schein, the total compensation of Barry Alperin at Henry Schein is $318,000. There are 12 executives at Henry Schein getting paid more, with Stanley Bergman having the highest compensation of $14,422,900.

How old is Barry Alperin?

Barry Alperin is 79, he's been the Independent Director of Henry Schein since 1996. There are no older and 33 younger executives at Henry Schein.

What's Barry Alperin's mailing address?

Barry's mailing address filed with the SEC is C/O JEFFERIES FINANCIAL GROUP INC., 520 MADISON AVE., NEW YORK, NY, 10022.

Insiders trading at Henry Schein

Over the last 22 years, insiders at Henry Schein have traded over $272,732,340 worth of Henry Schein stock and bought 23,637 units worth $1,414,559 . The most active insiders traders include Stanley M Bergman, Norman S Matthews, and Deborah Derby. On average, Henry Schein executives and independent directors trade stock every 21 days with the average trade being worth of $1,074,342. The most recent stock trade was executed by Lorelei Mc Glynn on 6 September 2024, trading 21,035 units of HSIC stock currently worth $1,457,726.

What does Henry Schein do?

henry schein, inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. the company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. a fortune 500® company and a member of the s&p 500® and nasdaq 100® indexes, henry schein employs more than 18,000 team schein members and serves more than one million customers. the company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. henry schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and henry schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. the company also offers its customers exclusive, innovative technology solutions, including practice

Complete history of Mr. Alperin stock trades at Fiesta Restaurant Inc, Henry Schein, Hain Celestial Inc, and Jefferies Inc

Henry Schein executives and stock owners

Henry Schein executives and other stock owners filed with the SEC include:

• Stanley Bergman,
  Chairman of the Board, Chief Executive Officer
• Stanley M. Bergman,
  Exec. Chairman & CEO
• Steven Paladino,
  Chief Financial Officer, Executive Vice President, Director
• Gerald Benjamin,
  Chief Administrative Officer, Executive Vice President, Director
• James Breslawski,
  President, Vice Chairman of the Board, Director
• Mark Mlotek,
  Chief Strategic Officer, Executive Vice President, Director
• James P. Breslawski,
  Exec. Vice Chairman & Pres
• Gerald A. Benjamin,
  Exec. VP, Chief Admin. Officer & Exec. Director
• Steven Paladino,
  Exec. VP, CFO & Exec. Director
• Mark E. Mlotek,
  Exec. VP, Chief Strategic Officer & Exec. Director
• Michael Racioppi,
  Senior Vice President, Chief Merchandising Officer
• Philip Laskawy,
  Lead Independent Director
• Barry Alperin,
  Independent Director
• Joseph Herring,
  Independent Director
• Kurt Kuehn,
  Independent Director
• Bradley Sheares,
  Independent Director
• Carol Raphael,
  Independent Director
• Anne Margulies,
  Independent Director
• Elizabeth Rekow,
  Independent Director
• Shira Goodman,
  Independent Director
• Paul Brons,
  Independent Director
• James Mullins,
  Senior Vice President of Global Services
• Rene Willi,
  President, Global Dental Surgical Group
• David Brous,
  President, Strategic Business Units Group and Asia Pacific & Brazil Dental
• Steven Kess,
  President of the Santa Fe Group
• Carolynne Borders,
  Vice President - Investor Relations
• Jonathan Koch,
  Senior Vice President and Chief Executive Officer, Global Dental Group and Interim Chief Executive Officer, Henry Schein One
• Michael Ettinger,
  Senior Vice President - Corporate and Legal Affairs, Chief of Staff, Secretary
• Lorelei McGlynn,
  Chief Human Resource Officer
• Walter Siegel,
  Senior Vice President, General Counsel
• Christopher Pendergast,
  Senior Vice President, Chief Technology Officer
• Brad Connett,
  President - Henry Schein's U.S. Medical Group
• Olga Timoshkina,
  VP of Corp. Fin., Chief Accounting Officer & Corp. Controller
• Michael Saul Ettinger,
  Exec. VP & COO
• Ronald N. South,
  Sr. VP & CFO
• John Lee,
  VP of Global Compensation & Benefits
• Walter Siegel,
  Chief Legal Officer
• Graham Stanley,
  VP of Investor Relations & Strategic Fin. Project Officer
• Christopher Pendergast,
  Sr. VP & CTO
• Ronald South,
  Chief Accounting Officer & VP of Corp. Fin.
• Paul Rose,
  SVP, Global Supply Chain
• David Mc Kinley,
  President, Medical Group
• Donald J Kabat,
  Director
• Karen Prange,
  EVP&CEO Gl.AH.Med.Den.Sur.Grp
• Lawrence S Bacow,
  Director
• Robert Minowitz,
  President, Int'l Dental Group
• E Dianne Rekow,
  Director
• Peter M. Mc Carthy,
  Pres., Global Animal Health
• Bridget A Ross,
  President, Global Medical Grp
• James A. Harding,
  Chief Technology Officer
• Mohamad Ali,
  
• Deborah Derby,
  
• Michael Zack,
  Senior Vice President
• Larry Gibson,
  Executive V.P. and CTO
• Irving Shafran,
  Director
• Margaret A Hamburg,
  Director
• Marvin Schein,
  
• Pamela Joseph,
  Director
• Stanley Komaroff,
  Senior Advisor
• Lonnie Shoff,
  Pres., Global Healthcare Spec.
• Norman S Matthews,
  Director
• Louis W Sullivan,
  Director
• Karyn Mashima,
  Director
• Leonard A David,
  Vice President
• Reed Vaughn Tuckson,
  
• Scott Philip Serota,
  
• Carole T Faig,
  
• Ronald N. South,
  SVP & Chief Financial Officer